- Home
- Publications
- Publication Search
- Publication Details
Title
Malignancy Rates in Brodalumab Clinical Studies for Psoriasis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-24
DOI
10.1007/s40257-020-00512-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn’s Disease With up to 6 Years of Follow-Up in the Pyramid Registry
- (2018) Geert D’Haens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?
- (2018) Yuehong Chen et al. CYTOKINE
- CME Part I Psoriasis: Which Therapy for Which Patient Psoriasis comorbidities and preferred systemic agents
- (2018) Shivani B. Kaushik et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Systematic review of the real-world evidence of adalimumab safety in psoriasis registries
- (2018) B. Strober et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Safety of Ixekizumab in Patients with Psoriatic Arthritis: Results from a Pooled Analysis of Three Clinical Trials
- (2018) Philip Mease et al. ARTHRITIS CARE & RESEARCH
- Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry
- (2017) David Fiorentino et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data
- (2017) Bruce Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Spotlight on brodalumab in the treatment of moderate-to-severe plaque psoriasis: design, development, and potential place in therapy
- (2017) Michael Roman et al. Drug Design Development and Therapy
- Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers
- (2016) Karin Hellgren et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
- (2016) Louise K Mercer et al. ANNALS OF THE RHEUMATIC DISEASES
- A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
- (2016) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
- (2016) Peter C.M. van de Kerkhof et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States
- (2015) A.B. Kimball et al. BRITISH JOURNAL OF DERMATOLOGY
- Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses
- (2015) Yuehong Chen et al. CLINICAL RHEUMATOLOGY
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of brodalumab for psoriasis after 120 weeks of treatment
- (2014) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
- (2013) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Melanoma associated with tumour necrosis factor-α inhibitors: a Research on Adverse Drug events And Reports (RADAR) project
- (2013) B. Nardone et al. BRITISH JOURNAL OF DERMATOLOGY
- Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies
- (2013) C. Pouplard et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A balance of interleukin-12 and -23 in cancer
- (2013) Shin Foong Ngiow et al. TRENDS IN IMMUNOLOGY
- Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
- (2013) P. Raaschou et al. BMJ-British Medical Journal
- Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
- (2012) Michele W. L. Teng et al. CANCER RESEARCH
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Psoriasis and Risk of Incident Cancer: An Inception Cohort Study with a Nested Case–Control Analysis
- (2009) Yolanda B. Brauchli et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening
- (2008) Alexa B. Kimball et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now